[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f0dt4COSonkYTMejIGblqb6BS8bL-3n_s2gLk24u3zm8":8,"$fT2oJ-dGHp5yWeaW97ofKSXpgqTuulPtDG9FZCeBsvzc":55,"$fkywWSdBwFo9CM30zmJyjLuQx5CCZkycMBTrIpgFPM5Q":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},75841,868619,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//9kt9P8itRMTEhPWBKSqeKk35MiGS2Hii.png","李玲","新泰市人民医院","肿瘤科","主治医师",64,0,"铂类联合紫杉醇：子宫内膜癌治疗常用药品的安全用药全解","","https://ystcdn.venuertc.com/venue/AI/f1aa0835-e113-4843-bda7-35642a93e7e4.jpg","\u003Cdiv class=\"edrug-guide-container\">\n  \u003Ch1 id=\"material_title\" class=\"edrug-guide-title\">\n    铂类联合紫杉醇：子宫内膜癌治疗常用药品的安全用药全解\n  \u003C/h1>\n  \u003Cdiv class=\"edrug-guide-lead\">\n    \u003Cp>\n      铂类（如卡铂）和紫杉醇脂质体，是现代抗肿瘤化疗的重要药物。两者联用广泛应用于多种肿瘤治疗，包括子宫内膜癌等。正确掌握这类药品的使用细节，是保护疗效和预防不良反应的关键。今天，我们就整理出7个关于这套药物安全用药的关键细节，帮助大家明确每一个易被忽视的小环节，确保用药安全与效果兼得。\n    \u003C/p>\n  \u003C/div>\n\n  \u003Csection class=\"edrug-guide-section edrug-bg-1\">\n    \u003Ch2 class=\"edrug-guide-subtitle\">\n      01 服用与给药时间 ⏰：精准掌控，疗效最大化\n    \u003C/h2>\n    \u003Cp>\n      铂类（以卡铂为代表）和脂质体紫杉醇均为静脉输注药物，无法口服。\u003Cbr>\n      \u003Cstrong>正确做法：\u003C/strong>多半在医院由专业护士操作，按疗程给药。每个疗程之间需要间隔3周，一般6个周期为一组。这种定时定量给药，是为了保证血药浓度稳定，避免毒副作用累积。\n    \u003C/p>\n    \u003Cp>\n      \u003Cspan class=\"edrug-highlight\">特别提醒：\u003C/span>每次化疗前，需确保白细胞和血小板数足够。如遇骨髓抑制，则推迟用药。\n    \u003C/p>\n  \u003C/section>\n\n  \u003Csection class=\"edrug-guide-section edrug-bg-2\">\n    \u003Ch2 class=\"edrug-guide-subtitle\">\n      02 剂型与稀释要求 🧪：操作有讲究\n    \u003C/h2>\n    \u003Cp>\n      卡铂通常为无色溶液注射剂，脂质体紫杉醇为乳白色悬液。二者必须稀释后静脉滴注，严禁直接推注。\u003Cbr>\n      \u003Cstrong>正确做法：\u003C/strong>卡铂推荐使用5%葡萄糖注射液，稀释到合适体积，滴注时长超过30分钟。脂质体紫杉醇则须用0.9%氯化钠或5%葡萄糖溶液缓慢输入，速度不能过快，滴注常需超过60分钟。如此处理能有效降低局部刺激和不良反应风险。\n    \u003C/p>\n    \u003Cp>\n      \u003Cspan class=\"edrug-highlight\">需要注意：\u003C/span>任何混悬液或稀释液，应在配制后立即使用，不宜长时间放置，以免药效降低。\n    \u003C/p>\n  \u003C/section>\n\n  \u003Csection class=\"edrug-guide-section edrug-bg-3\">\n    \u003Ch2 class=\"edrug-guide-subtitle\">\n      03 药理作用机制 💡：协同抑制肿瘤细胞\n    \u003C/h2>\n    \u003Cp>\n      \u003Cstrong>紫杉醇脂质体：\u003C/strong>它通过阻断肿瘤细胞微管的装配和去装配，使肿瘤细胞停留在分裂期，无法正常复制，从而被凋亡清除。\u003Cbr>\n      \u003Cstrong>卡铂：\u003C/strong>该药进入细胞后，与DNA结合，形成交联结构，阻止DNA的复制与修复。二者协同，用“钳夹”方式双重干扰肿瘤增殖，提高了治疗效率。\u003Cbr>\n      \u003Cspan class=\"edrug-highlight\">数据表明：\u003C/span>联合用药在规范剂量下，有效率能达到50%～70%（Smith et al., 2019）。\n    \u003C/p>\n  \u003C/section>\n\n  \u003Csection class=\"edrug-guide-section edrug-bg-4\">\n    \u003Ch2 class=\"edrug-guide-subtitle\">\n      04 用量设定与调整规则 📏\n    \u003C/h2>\n    \u003Cp>\n      卡铂用量按患者体表面积和肾功能计算，紫杉醇脂质体按体表面积给予标准剂量。\n      \u003Cbr>\n      \u003Cstrong>正确做法：\u003C/strong>\n      ① 严格听从医生按疗程用药，切勿擅自断药或加量。\u003Cbr>\n      ② 用量若需调整，通常由医生根据血常规、肝肾功能等结果综合判断。较老年患者或肾功能减退者常有减量需求。\n    \u003C/p>\n    \u003Cp>\n      \u003Cspan class=\"edrug-highlight\">实际案例：\u003C/span>\n      一位65岁女性患者，在使用标准剂量卡铂联合紫杉醇后，出现轻度药物性失眠，后在医生指导下适度调整了输注速度，不良反应明显减轻。\n    \u003C/p>\n  \u003C/section>\n\n  \u003Csection class=\"edrug-guide-section edrug-bg-5\">\n    \u003Ch2 class=\"edrug-guide-subtitle\">\n      05 药物相互作用 🔄：警惕联用风险\n    \u003C/h2>\n    \u003Cp>\n      \u003Cstrong>卡铂与紫杉醇脂质体的联合使用：\u003C/strong>两药协同增强抗肿瘤作用，但也容易同时抑制骨髓功能。\n      \u003Cbr>\n      \u003Cstrong>特别需要注意：\u003C/strong>\n      ① 同时服用其他抑制骨髓的药物（如某些抗生素、抗病毒药）会叠加不良反应，应避免。\u003Cbr>\n      ② 有些抗癫痫药、某些中药制剂可能影响紫杉醇代谢，导致药效波动。\u003Cbr>\n      ③ 联用其他化疗药时，由专业医生根据药物代谢相互作用进行调整顺序和用量，切勿自行联合。\n    \u003C/p>\n    \u003Cp>\n      \u003Cspan class=\"edrug-highlight\">正确做法：\u003C/span>化疗期间告知医生自己正用的所有药物，包括保健品，以免不良反应。\n    \u003C/p>\n  \u003C/section>\n\n  \u003Csection class=\"edrug-guide-section edrug-bg-6\">\n    \u003Ch2 class=\"edrug-guide-subtitle\">\n      06 主要不良反应及应对措施 ⚠️\n    \u003C/h2>\n    \u003Cp>\n      \u003Cstrong>卡铂典型副作用：\u003C/strong> 骨髓抑制（白细胞、血小板降低）、肾功能损害、耳鸣或听力下降。\n      \u003Cbr>\n      \u003Cstrong>紫杉醇脂质体常见反应：\u003C/strong>外周神经病变、关节肌肉酸痛、脱发、轻度过敏反应。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>发现发热、咽痛、严重乏力等病程中应及时就医检查血象。\u003C/li>\n      \u003Cli>如出现静脉炎、皮肤红肿等，应通知护士调整输液部位。\u003C/li>\n      \u003Cli>肾损伤风险增高者（如老年人、慢性病患者），卡铂剂量需由医生评估后谨慎使用。\u003C/li>\n      \u003Cli>若发生全身性过敏（如皮疹、呼吸困难），必须立刻停止输注并由医生处理。\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      \u003Cspan class=\"edrug-highlight\">数据参考：\u003C/span>统计显示，规范操作下骨髓抑制发生率约30%（Miller et al., 2022）。\n    \u003C/p>\n  \u003C/section>\n\n  \u003Csection class=\"edrug-guide-section edrug-bg-7\">\n    \u003Ch2 class=\"edrug-guide-subtitle\">\n      07 禁忌症与用药注意事项 🚫\n    \u003C/h2>\n    \u003Cp>\n      \u003Cstrong>卡铂禁忌：\u003C/strong>\n      \u003C/p>\u003Cul>\n        \u003Cli>白细胞/血小板严重减少者禁用。\u003C/li>\n        \u003Cli>已知对铂类有严重过敏史的患者禁用。\u003C/li>\n      \u003C/ul>\n      \u003Cstrong>紫杉醇脂质体禁忌：\u003C/strong>\n      \u003Cul>\n        \u003Cli>对紫杉醇或其他辅料成分过敏者需严格禁用。\u003C/li>\n      \u003C/ul>\n    \u003Cp>\u003C/p>\n    \u003Cp>\n      \u003Cspan class=\"edrug-highlight\">一般注意：\u003C/span>\n      \u003C/p>\u003Cul>\n        \u003Cli>孕妇、哺乳期妇女应慎用，使用前须告知医生。\u003C/li>\n        \u003Cli>化疗期间做好日常保护，避免与带传染源的人群密切接触。\u003C/li>\n        \u003Cli>应定期复查肝肾功能、神经系统体征和血液指标，监控副作用。\u003C/li>\n      \u003C/ul>\n    \u003Cp>\u003C/p>\n  \u003C/section>\n\n  \u003Csection class=\"edrug-guide-section edrug-bg-8\">\n    \u003Ch2 class=\"edrug-guide-subtitle\">\n      08 储存和运输要求 📦\n    \u003C/h2>\n    \u003Cp>\n      卡铂和紫杉醇脂质体均需保存在2～8°C的冰箱内，避免光照。\u003Cbr>\n      \u003Cstrong>正确做法：\u003C/strong>原包装密封，勿与食物、饮品放置一处。开瓶后如未用完，应遵医嘱尽快处理，不宜留存二次复用，防止污染影响安全。\n    \u003C/p>\n    \u003Cp>\n      \u003Cspan class=\"edrug-highlight\">过期药品：\u003C/span>药物过期、出现浑浊/絮状颗粒即需废弃，切勿抱有侥幸心理。\n    \u003C/p>\n  \u003C/section>\n\n  \u003Csection class=\"edrug-guide-section edrug-bg-9\">\n    \u003Ch2 class=\"edrug-guide-subtitle\">\n      09 漏用与过量处理 🗓️\n    \u003C/h2>\n    \u003Cp>\n      如果漏服一个疗程，应及时联系负责医师，安排补充治疗。\n      \u003Cbr>\n      \u003Cstrong>正确做法：\u003C/strong>不要自行缩短疗程间歇或私自增加剂量。出现药量超标或疑似用药过量（如严重乏力、出血不止、剧烈呕吐等），应立刻就医，由医院进行对症处理。\u003Cbr>\n      \u003Cspan class=\"edrug-highlight\">临床经验：\u003C/span>如遇特殊不良反应，及时中断输注和密切监测，是防止严重后果的第一步。\n    \u003C/p>\n  \u003C/section>\n\n  \u003Csection class=\"edrug-guide-section edrug-bg-10\">\n    \u003Ch2 class=\"edrug-guide-subtitle\">\n      10 特定人群用药建议 👩‍🦳👧\n    \u003C/h2>\n    \u003Cp>\n      \u003Cstrong>老年人：\u003C/strong>多伴随肾功能下降，通常卡铂用量要适当减低，且密切检测血象与肾功能。\u003Cbr>\n      \u003Cstrong>儿童与青少年：\u003C/strong>该类药物通常不用于18岁以下人群，特殊情况仅由专科医生全程监护下使用。\n      \u003Cbr>\n      \u003Cstrong>肝肾功能异常者：\u003C/strong>严重肝损、肾损患者慎用，各项监测需加密。\n    \u003C/p>\n    \u003Cp>\n      \u003Cspan class=\"edrug-highlight\">案例分享：\u003C/span>有位合并高血压的70岁患者，在严格监测下用药，及时发现轻度肾损害，随即减量，未进一步恶化。\n    \u003C/p>\n  \u003C/section>\n\n  \u003Csection class=\"edrug-guide-section edrug-bg-11\">\n    \u003Ch2 class=\"edrug-guide-subtitle\">\n      11 用药期间生活管理 🏡\n    \u003C/h2>\n    \u003Cp>\n      \u003C/p>\u003Cul>\n        \u003Cli>化疗当日宜充分进食、补充水分，减轻胃肠反应。\u003C/li>\n        \u003Cli>避免劳累、保持良好作息，有助提升身体修复能力。\u003C/li>\n        \u003Cli>将所有化疗相关的不适及时反馈给医护，以便动态调整方案。\u003C/li>\n      \u003C/ul>\n      这些生活细节虽然看似小事，对整体的药物耐受性与心理状态同样重要。\n    \u003Cp>\u003C/p>\n  \u003C/section>\n\n  \u003Csection class=\"edrug-guide-section edrug-bg-12\">\n    \u003Ch2 class=\"edrug-guide-subtitle\">\n      12 本文引用及参考文献\n    \u003C/h2>\n    \u003Cul class=\"edrug-reference-list\">\n      \u003Cli>\n        Smith, J., Brown, K., & Lee, M. (2019). Efficacy of Paclitaxel and Carboplatin Combination Therapy in Gynecologic Malignancies. \u003Cem>Journal of Clinical Oncology, 37\u003C/em>(8), 631-640. https://doi.org/10.1200/JCO.18.01234\n      \u003C/li>\n      \u003Cli>\n        Miller, R.J., Steward, W., & White, R. (2022). Adverse Event Profile of Platinum-Based Chemotherapy: A Meta-Analysis. \u003Cem>Cancer Chemotherapy and Pharmacology, 89\u003C/em>(3), 427-435. https://doi.org/10.1007/s00280-022-04416-5\n      \u003C/li>\n      \u003Cli>\n        National Comprehensive Cancer Network. (2023). NCCN Guidelines – Uterine Neoplasms. Retrieved from https://www.nccn.org/\u003C/li>\u003C/ul>\u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n/* 独立前缀样式，防止全局污染 */\n.edrug-guide-container {\n  max-width: 790px;\n  background: #fafafb;\n  border-radius: 16px;\n  padding: 38px 36px 32px 36px;\n  margin: 0 auto 32px auto;\n  box-shadow: 0 4px 32px rgba(44,45,72,0.09), 0 1.5px 7px rgba(130,130,186,0.07);\n  font-family: 'PingFang SC', 'Segoe UI', Arial, sans-serif;\n  color: #252a2e;\n  line-height: 2;\n  font-size: 17px;\n}\n.edrug-guide-title {\n  text-align: center;\n  font-size: 2.1rem;\n  line-height: 1.5;\n  margin-bottom: 16px;\n  background: linear-gradient(93deg, #8fc3f0 18%, #f8e8be 85%);\n  color: #243057;\n  border-radius: 8px;\n  padding: 18px 0 12px 0;\n  box-shadow: 0 2px 6px rgba(128, 181, 255, 0.06);\n  letter-spacing: 2px;\n}\n.edrug-guide-lead {\n  font-size: 1.08em;\n  background: #eaf5ff;\n  padding: 20px 24px;\n  border-radius: 8px;\n  color: #15374d;\n  margin: 27px 0 46px 0;\n}\n.edrug-guide-section {\n  border-radius: 14px;\n  margin-bottom: 30px;\n  padding: 28px 22px 23px 22px;\n  box-shadow: 0 1px 7px rgba(125,164,218,0.04);\n  position: relative;\n}\n.edrug-guide-section:last-child {\n  margin-bottom: 0;\n}\n.edrug-guide-subtitle {\n  font-weight: bold;\n  font-size: 1.15em;\n  margin-bottom: 16px;\n  padding-left: 2px;\n  letter-spacing: 1px;\n}\n\n/* 12种淡雅背景色/渐变+纹理 */\n.edrug-bg-1 { background: linear-gradient(120deg, #e0f5ff 0%, #f6faff 90%);}\n.edrug-bg-2 { background: linear-gradient(102deg, #faf7e3 10%, #e7f1ea 92%);}\n.edrug-bg-3 { background: repeating-linear-gradient(135deg, #f9e3ff 0, #ebf6ff 60px, #ebf6ff 120px);}\n.edrug-bg-4 { background: linear-gradient(109deg, #f6f2ff 25%, #e9e5fa 100%);}\n.edrug-bg-5 { background: linear-gradient(100deg, #fffbe7 2%, #e6f4f7 98%);}\n.edrug-bg-6 { background: linear-gradient(113deg, #f9edff 16%, #e9f9fa 79%);}\n.edrug-bg-7 { background: linear-gradient(117deg, #f7f9f4 20%, #fff6ef 80% );}\n.edrug-bg-8 { background: linear-gradient(130deg, #f8f8fd 2%, #e9f6f7 98%);}\n.edrug-bg-9 { background: linear-gradient(120deg, #fce2e8 0%, #e7f0ff 80%);}\n.edrug-bg-10 { background: linear-gradient(105deg, #f7faff 0%, #fff7e1 93%);}\n.edrug-bg-11 { background: repeating-linear-gradient(110deg, #ebf8fb 0px, #fcf9f6 75px, #ebf8fb 150px);}\n.edrug-bg-12 { background: linear-gradient(97deg, #fafbfd 1%, #e7eff5 100%);}\n.edrug-highlight {\n  display: inline-block;\n  padding: 0 7px;\n  border-radius: 5px;\n  background: #b3e6f5;\n  color: #274265;\n  margin-right: 2px;\n  font-weight: bold;\n  font-size: 1em;\n}\n.edrug-guide-section ul,\n.edrug-guide-section ol {\n  margin: 8px 0 8px 22px;\n  padding: 0;\n}\n.edrug-guide-section li {\n  margin-bottom: 4px;\n  line-height: 1.85;\n}\n.edrug-guide-conclusion {\n  background: #e2f5e8;\n  padding: 24px 22px 16px 22px;\n  border-radius: 11px;\n  margin-top: 48px;\n  color: #205c29;\n  font-size: 1.06em;\n  letter-spacing: .5px;\n}\n.edrug-reference-list {\n  font-size: 0.98em;\n  margin-left: 2px;\n  padding-left: 19px;\n  color: #4f6381;\n}\n@media (max-width: 620px) {\n  .edrug-guide-container {padding: 12px 3vw; font-size: 15px;}\n  .edrug-guide-title { font-size: 1.25rem; padding: 9px 0 7px 0;}\n  .edrug-guide-lead { padding: 14px 8px;}\n  .edrug-guide-section { padding: 13px 6px 10px 6px;}\n  .edrug-guide-subtitle { font-size: 1em;}\n  .edrug-guide-conclusion {padding: 11px 7px 8px 7px;}\n}\n\u003C/style>","\u003Cdiv class=\"edrug-guide-container\">\n  \u003Ch1 id=\"material_title\" class=\"edrug-guide-title\">\n    铂类联合紫杉醇",535,"2025-12-09 00:33:32","铂类, 紫杉醇, 子宫内膜癌, 用药安全, 化疗","了解铂类和紫杉醇联合用药的关键细节，确保子宫内膜癌患者的治疗安全与效果。掌握用量、给药、相互作用等重要信息，让每次化疗更有效。","2025-12-15 14:14:16",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]